Dr. Cristina Gasparetto, MD
Claim this profileDuke University Hospital
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
9 reported clinical trials
19 drugs studied
Area of expertise
1Multiple Myeloma
t(4;14) positive
GOF mutation in MMSET positive
HLA-A positive
2Plasma Cell Neoplasms
t(4;14) positive
GOF mutation in MMSET positive
HLA-A positive
Affiliated Hospitals
Clinical Trials Cristina Gasparetto, MD is currently running
Iberdomide + Daratumumab vs. Bortezomib
for Multiple Myeloma
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).
Recruiting2 awards Phase 3
MMSET Inhibitor
for Multiple Myeloma
This trial tests a new pill that blocks an enzyme to help treat adults with a hard-to-treat type of blood cancer. The goal is to see if it is safe and effective.
Recruiting1 award Phase 113 criteria
More about Cristina Gasparetto, MD
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Cristina Gasparetto, MD has experience with
- Dexamethasone
- Bortezomib
- Lenalidomide
- Pomalidomide
- Iberdomide
- Daratumumab
Breakdown of trials Cristina Gasparetto, MD has run
Multiple Myeloma
Plasma Cell Neoplasms
Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cristina Gasparetto, MD specialize in?
Cristina Gasparetto, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved t(4;14) positive patients, or patients who are GOF mutation in MMSET positive.
Is Cristina Gasparetto, MD currently recruiting for clinical trials?
Yes, Cristina Gasparetto, MD is currently recruiting for 4 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Cristina Gasparetto, MD has studied deeply?
Yes, Cristina Gasparetto, MD has studied treatments such as Dexamethasone, Bortezomib, Lenalidomide.
What is the best way to schedule an appointment with Cristina Gasparetto, MD?
Apply for one of the trials that Cristina Gasparetto, MD is conducting.
What is the office address of Cristina Gasparetto, MD?
The office of Cristina Gasparetto, MD is located at: Duke University Hospital, Durham, North Carolina 27705-3976 United States. This is the address for their practice at the Duke University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.